People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Other Technology, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | — | Other Technology | Series C | $122.1M | $1.1B | 2009 |
| Prolacta Bioscience Inc | — | Biotechnology | Series B | $64.7M | $353.6M | 2016 |
| Sleep Solutions Inc | — | Other Health Care | Series B | $20.0M | $443.1M | 2009 |
Ned Brown at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ned Brown on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Foster | 1 | 12 |
| Annette Campbell-White | 1 | 11 |
| Adele Oliva | 1 | 9 |
| John Shields | 1 | 6 |
| Edward L. Cahill | 1 | 4 |
| David Brailer | 1 | 4 |
| Jesse Treu | 1 | 4 |
| Douglas A. Roeder | 1 | 4 |
| Dan Janney | 1 | 4 |
| DICK ALLEN | 1 | 3 |
| Kevin Quinn | 1 | 3 |
| Keith Grossman | 1 | 3 |
| David Dreyer | 1 | 3 |
| Paul A. Sekhri | 1 | 2 |
| Howard E. Greene | 1 | 2 |
| Frank D. Foster | 1 | 2 |
| Martin Sutter | 1 | 2 |
| Victoria Niklas | 1 | 2 |
| John H. Cajigas | 1 | 1 |
| Jesse H. Treu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.